|
Volkova A.R., Fishman M.B., Semikova G.V, Somova V.M., Mozgunova V.S.
Clinical predictors of weight regain after bariatric surgery
|
№8 / 2020
|
|
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V.
Kidney damage in case of obesity: variants of clinical course, mechanisms of development
|
№6 / 2019
|
|
Ametov A.S., Rubtsov Yu.E., Saluhov V.V., Khalimov Yu.Sh., Agafonov P.V.
Elimination of adipose tissue dysfunction as a major factor in reducing cardiometabolic risks in obesity
|
№6 / 2019
|
|
Yagoda A.V., Geyvandova T.V., Rogova S.Sh., Geyvandova N.I.
The clinical significance of blood leptin in patients with non-alcoholic fatty liver disease associated with obesity
|
№3 / 2019
|
|
C.G. Shul'kina, E.N. Smirnova
Metabolically healthy obesity - focus on endothelium and inflammation
|
№3 / 2018
|
|
O.A. Gromova, I.Yu. Torshin, V.F. Zgoda, I.К. Tomilova
Molecular mechanisms of action of Laennec against development of metabolic syndrome and obesity
|
№5 / 2017
|
|
A.Ye. Goldshmid., Ye.Yu. Martynova, Yu.Ye. Poteshkin
Obesity: modern concept of diagnosis and treatment
|
№5 / 2017
|
|
L.V. Kondratieva, T.V. Popkova, Ye.L. Nasonov
Prevalence of traditional risk factors for type 2 diabetes mellitus in patients with rheumatoid arthritis
|
№4 / 2017
|
|
O.A. Gromova, A.G. Kalacheva, I.Yu. Torshin, T.R. Grishina, N.I. Tapilskaya
Deficiencies of magnesium and pyridoxine and the pathogenesis of the metabolic syndrome
|
№3 / 2017
|
|
T.Yu. Demidova, M.V. Stelmakh
Modern facilities and future prospects in pharmacotherapy of obesity
|
№4 / 2016
|
|
T.I. Romantsova
Molecular mechanisms of body weight regulation as targets for pathogenetic therapy of obesity
|
№4 / 2015
|
Русский
